News | September 11, 2024
Evonik starts operation of new spray drying facility for pharmaceutical oral excipients
Investment in new plant meets increasing demand for functional excipients for oral drug delivery
Investment in new plant meets increasing demand for functional excipients for oral drug delivery
Collaboration with KNAUER to streamline and improve the scale-up of LNP formulations
Yann d’Hervé takes over responsibility for the Health Care business at Evonik, effective July 1
New solvent-free micronization technology expanded at the Darmstadt site in Germany
Aims to become a leading global partner for botanical extracts and natural actives in the beauty and personal care market
Reconfirms a relative bioavailability of 65 percent and significant savings when using DL-methionine
Grand opening of the joint venture between Evonik China and Shandong Vland Biotech in Qingdao, China
More than 10,000 scientific publications containing EUDRAGIT
New institute brings together Evonik’s most advanced biotech platform and a global network of evaluation labs
Commercialization of rPEG lipids designed to improve immunogenicity profile for nucleic acid delivery
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
